219 related articles for article (PubMed ID: 19282460)
21. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines.
Klein C; Bueler H; Mulligan RC
J Exp Med; 2000 May; 191(10):1699-708. PubMed ID: 10811863
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination.
Sun X; Hodge LM; Jones HP; Tabor L; Simecka JW
Vaccine; 2002 Jan; 20(9-10):1466-74. PubMed ID: 11818167
[TBL] [Abstract][Full Text] [Related]
23. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells.
Greter M; Helft J; Chow A; Hashimoto D; Mortha A; Agudo-Cantero J; Bogunovic M; Gautier EL; Miller J; Leboeuf M; Lu G; Aloman C; Brown BD; Pollard JW; Xiong H; Randolph GJ; Chipuk JE; Frenette PS; Merad M
Immunity; 2012 Jun; 36(6):1031-46. PubMed ID: 22749353
[TBL] [Abstract][Full Text] [Related]
24. Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction.
Abe J; Wakimoto H; Yoshida Y; Aoyagi M; Hirakawa K; Hamada H
J Cancer Res Clin Oncol; 1995; 121(9-10):587-92. PubMed ID: 7559742
[TBL] [Abstract][Full Text] [Related]
25. IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor.
Murphy JM; Young IG
Vitam Horm; 2006; 74():1-30. PubMed ID: 17027509
[TBL] [Abstract][Full Text] [Related]
26. Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly.
Ishino T; Harrington AE; Zaks-Zilberman M; Scibek JJ; Chaiken I
Cytokine; 2008 May; 42(2):179-190. PubMed ID: 18294864
[TBL] [Abstract][Full Text] [Related]
27. MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.
Herrlinger U; Aulwurm S; Strik H; Weit S; Naumann U; Weller M
J Neurooncol; 2004 Jan; 66(1-2):147-54. PubMed ID: 15015780
[TBL] [Abstract][Full Text] [Related]
28. Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models.
Wang H; Tumes DJ; Hercus TR; Yip KH; Aloe C; Vlahos R; Lopez AF; Wilson N; Owczarek CM; Bozinovski S
Cell Death Dis; 2022 Feb; 13(2):137. PubMed ID: 35145069
[TBL] [Abstract][Full Text] [Related]
29. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
[TBL] [Abstract][Full Text] [Related]
30. GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation.
Dougan M; Dranoff G; Dougan SK
Immunity; 2019 Apr; 50(4):796-811. PubMed ID: 30995500
[TBL] [Abstract][Full Text] [Related]
31. Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors.
Campisano S; Mac Keon S; Gazzaniga S; Ruiz MS; Traian MD; Mordoh J; Wainstok R
Vaccine; 2013 Jan; 31(2):354-61. PubMed ID: 23146677
[TBL] [Abstract][Full Text] [Related]
32. Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunity.
McLaughlin JP; Abrams S; Kantor J; Dobrzanski MJ; Greenbaum J; Schlom J; Greiner JW
J Immunother; 1997 Nov; 20(6):449-59. PubMed ID: 9409450
[TBL] [Abstract][Full Text] [Related]
33. Antitumor Effect on Murine Renal Cell Carcinoma by Autologous Tumor Vaccines Genetically Modified with Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-6 Cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother (1991); 2001 May; 24(3):205-211. PubMed ID: 11395635
[TBL] [Abstract][Full Text] [Related]
34. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
Wakimoto H; Abe J; Tsunoda R; Aoyagi M; Hirakawa K; Hamada H
Cancer Res; 1996 Apr; 56(8):1828-33. PubMed ID: 8620500
[TBL] [Abstract][Full Text] [Related]
35. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
[TBL] [Abstract][Full Text] [Related]
36. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.
Simons JW; Jaffee EM; Weber CE; Levitsky HI; Nelson WG; Carducci MA; Lazenby AJ; Cohen LK; Finn CC; Clift SM; Hauda KM; Beck LA; Leiferman KM; Owens AH; Piantadosi S; Dranoff G; Mulligan RC; Pardoll DM; Marshall FF
Cancer Res; 1997 Apr; 57(8):1537-46. PubMed ID: 9108457
[TBL] [Abstract][Full Text] [Related]
37. Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy.
Li B; VanRoey MJ; Jooss K
Clin Immunol; 2007 May; 123(2):155-65. PubMed ID: 17320482
[TBL] [Abstract][Full Text] [Related]
38. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin receptor haploinsufficiency and in vivo interplay with granulocyte-macrophage colony-stimulating factor and interleukin 3.
Jegalian AG; Acurio A; Dranoff G; Wu H
Blood; 2002 Apr; 99(7):2603-5. PubMed ID: 11895800
[TBL] [Abstract][Full Text] [Related]
40. Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.
Thompson RC; Pardoll DM; Jaffee EM; Ewend MG; Thomas MC; Tyler BM; Brem H
J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):405-13. PubMed ID: 9041459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
